News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cerus Corporation (CERS) Reports Fourth Quarter and Year-End 2012 Results


3/1/2013 7:09:53 AM

Cerus Corporation (NASDAQ: CERS) today announced financial results for the fourth quarter and year ended December 31, 2012.

"We believe 2013 will be a pivotal year for Cerus in which we plan to both complete our INTERCEPT plasma PMA submission and begin planning for the PMA filing for INTERCEPT platelets,“ said William "Obi" Greenman, president and chief executive officer of Cerus Corporation.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES